TABLE 3.

Subgroup analyses of cardamom consumption on inflammatory factors in adults.

	Number of studies	WMD (95% CI)	p‐Value	p‐Value heterogeneity	I 2 (%)	p for between‐subgroup heterogeneity
Subgroup analyses of cardamom consumption on IL6
Trial duration (week)
≤10	2	−0.856 (−1.393, −0.319)	.002	.026	79.9	.112
>10	2	−1.335 (−1.581, −1.088)	<.001	<.001	98.0
Sex
Female	2	−0.932 (−1.182, −0.681)	<.001	.046	74.9	<.001
Female/male	2	−2.521 (−3.020, −2.022)	<.001	<.001	95.7
Subgroup analyses of cardamom consumption on hs‐CRP
Trial duration (week)
<10	2	−0.224 a (−0.535, 0.088)	.159	.094	64.3	.004
≥10	3	−0.783 a (−0.997, −0.570)	<.001	.753	0.0
Sex
Female	2	−0.703 a (−0.948, −0.459)	<.001	.273	16.7	.253
Female/male	3	−0.498 a (−0.752, −0.244)	<.001	.010	78.5

^a Standardized mean difference.